Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Creative Medical Technology approves $100,000 CEO and $25,000 CFO bonuses

Neutral Impact 2 of 5 leadership Written later

Creative Medical Technology Holdings' Compensation Committee approved bonuses of $100,000 for CEO Timothy Warbington and $25,000 for CFO Donald Dickerson on November 6, 2025, according to an 8-K filed November 12, 2025. The filing does not state the basis for the bonuses or any performance criteria, and it contains no financial results or changes in officer roles.

Key points

  • Compensation Committee approved the bonuses on November 6, 2025
  • CEO Timothy Warbington: $100,000 bonus
  • CFO Donald Dickerson: $25,000 bonus

The filing

CompanyCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
Form8-K, current report
Filed with the SECNov 12, 2025, 6:12 AM ET
Accession number0001477932-25-008027

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 12, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.